ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

Model to improve specificity for identification of clinically-relevant expanded T cells in peripheral blood.

Rytlewski et al.
PLOS ONE
March 2019
Authors and Affiliates
Rytlewski J1, Deng S2, Xie T2, Davis C2, Robins H1,3, Yusko E1, Bienkowska J2 1 Adaptive Biotechnologies, Seattle, Washington, United States of America. 2 Pfizer Incorporated, La Jolla, California, United States of America. 3 Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.